Discrepancies between Office and Ambulatory Blood Pressure: Clinical Implications
Authors:
- Franz H. MesserliFMFranz H. Messerli
- Bernard WaeberBWBernard Waeber
- Fernando Rodríguez-ArtalejoFRFernando Rodríguez-Artalejo
- Alex de la SierraASAlex de la Sierra
- Julián SeguraJSJulián Segura
- Alex Roca-CusachsARAlex Roca-Cusachs
- Pedro ArandaPAPedro Aranda
- Luis M. RuilopeLRLuis M. Ruilope
- 1 December 2009
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 122 (12) , 1136-1141
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Telmisartan to Prevent Recurrent Stroke and Cardiovascular EventsNew England Journal of Medicine, 2008
- Effectiveness of Blood Pressure Control Outside the Medical SettingHypertension, 2007
- Angiotensin-Converting Enzyme Inhibitors and Calcium Channel Blockers for Coronary Heart Disease and Stroke PreventionHypertension, 2005
- Superiority of Ambulatory Over Clinic Blood Pressure Measurement in Predicting MortalityHypertension, 2005
- Prognostic Value of Ambulatory and Home Blood Pressures Compared With Office Blood Pressure in the General PopulationCirculation, 2005
- Ambulatory Blood Pressure and MortalityHypertension, 2005
- Ambulatory Blood Pressure and 10-Year Risk of Cardiovascular and Noncardiovascular MortalityHypertension, 2005
- Recommendations for Blood Pressure Measurement in Humans and Experimental AnimalsHypertension, 2005
- Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA, 2002
- Comparative Effects of Ramipril on Ambulatory and Office Blood PressuresHypertension, 2001